Literature DB >> 32377252

METHIMAZOLE-INDUCED AGRANULOCYTOSIS AND SEPSIS: WAS THYROID STORM PRESENT OR JUST BEING MIMICKED?

M A M Stumpf1, G C A Schrut1, M Ramthun1, S Onuma1, H E C G Osternack1.   

Abstract

INTRODUCTION: Agranulocytosis induced by thioamides is rare, occurring only in 0.2-0.5% of cases. CASE
PRESENTATION: We present the case of a 45-year-old woman previously diagnosed with Graves' disease that discontinued the use of methimazole on her own. She attended the Emergency Department presenting fever (40.5¯C), agitation and diaphoresis. A thyroid storm diagnosis was initially thought, but after laboratory results showing neutrophil count near 0.06x109/L, sepsis due to neutropenia seemed the most logical hypothesis. Cephepime was promptly initiated. For thyrotoxicosis management, cholestyramine and atenolol were prescribed. In her second day of hospitalization, subcutaneous granulocyte colony-stimulating factor was started for an earlier medullar response. The patient was discharged after 7 days with atenolol 50mg/day and instructed to have a definite treatment for Graves disease as soon as possible.
CONCLUSION: Such case purpose is to remember clinicians that sepsis diagnosis can be challenged, especially when a thyroid storm is a possible diagnosis as well. In this particular case, both conditions should be treated, but life-threatening sepsis should have the focus for a quick therapeutic approach. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Agranulocytosis; Graves’ disease; Methimazole; Sepsis; Thyroid Crisis

Year:  2019        PMID: 32377252      PMCID: PMC7200104          DOI: 10.4183/aeb.2019.522

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  9 in total

Review 1.  Thyroid storm: an updated review.

Authors:  Maguy Chiha; Shanika Samarasinghe; Adam S Kabaker
Journal:  J Intensive Care Med       Date:  2013-08-05       Impact factor: 3.510

Review 2.  Delayed anithyroid drug-induced agranulocytosis.

Authors:  Priscilla Mutharasan; Wendy Oatis; Hau Kwaan; Mark Molitch
Journal:  Endocr Pract       Date:  2012 Jul-Aug       Impact factor: 3.443

3.  Sepsis mimicking thyroid storm in a patient with methimazole-induced agranulocytosis.

Authors:  Samuel G Rayner; Faegheh Hosseini; Adeyinka A Adedipe
Journal:  BMJ Case Rep       Date:  2013-07-16

Review 4.  Neutropenic Fever.

Authors:  Lindsey White; Michael Ybarra
Journal:  Hematol Oncol Clin North Am       Date:  2017-12       Impact factor: 3.722

5.  Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

Authors:  Balasubramanian Venkatesh; Simon Finfer; Jeremy Cohen; Dorrilyn Rajbhandari; Yaseen Arabi; Rinaldo Bellomo; Laurent Billot; Maryam Correa; Parisa Glass; Meg Harward; Christopher Joyce; Qiang Li; Colin McArthur; Anders Perner; Andrew Rhodes; Kelly Thompson; Steve Webb; John Myburgh
Journal:  N Engl J Med       Date:  2018-01-19       Impact factor: 91.245

6.  A patient with agranulocytosis following the discontinuation of methimazole treatment for 4 months: A case report.

Authors:  Xiao-Su Bai; Jing-Hai Liu; Shao-Mei Xiao
Journal:  Exp Ther Med       Date:  2014-06-30       Impact factor: 2.447

Review 7.  Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management.

Authors:  Nuno Vicente; Luís Cardoso; Luísa Barros; Francisco Carrilho
Journal:  Drugs R D       Date:  2017-03

8.  Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case.

Authors:  Rıfkı Üçler; Murat Atmaca; Ömer Candar; Murat Alay; Burhan Göy; Erdal Kara; Mahfuz Turan; Yusuf Demir
Journal:  Case Rep Endocrinol       Date:  2015-08-03

9.  Thyroidectomy for the treatment of Graves' thyrotoxicosis in thioamide-induced agranulocytosis and sepsis.

Authors:  Colin L Knight; Shamil D Cooray; Jaideep Kulkarni; Michael Borschmann; Mark Kotowicz
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-09-04
  9 in total
  1 in total

1.  A Rare Clinical Manifestation of Graves' Disease: Evans Syndrome and a Review of the Literature.

Authors:  M Calapkulu; M E Sencar; A Yıldız; I O Unsal; E Cakal
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.